nach oben

Current Atherosclerosis Reports

Erschienen in:

01.07.2022 | COVID-19 | Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors)

COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave

verfasst von: Ahmed A. Kolkailah, Kayla Riggs, Ann Marie Navar, Amit Khera

Erschienen in: Current Atherosclerosis Reports | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review the current evidence regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on cardiometabolic health, with a focus on strategies to help mitigate adverse effects on population health.

Recent Findings

Individuals with cardiometabolic disease are particularly vulnerable to worse outcomes with COVID-19 infection. In addition, the pandemic itself has had significant deleterious impact on the cardiometabolic health of the population, including declines in physical activity, increases in smoking and alcohol use, worsening blood pressure and glycemic control, and detrimental effects on mental health. Targeted interventions at the patient and community level will be needed to mitigate the long-term consequences of the COVID-19 pandemic on population cardiometabolic health.

Summary

The COVID-19 pandemic has worsened cardiometabolic health, but there are several opportunities and enhanced tools available to counteract these changes.

Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, Rosenblatt A, Walchok J, Omar W, Khera R, Hegde AA, Drazner MH, Neeland IJ, Grodin JL. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021;143:135–44.PubMedCrossRef

Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, Li Z, Shaw SF, Caparosa SL, Nau CL, Saxena T, Rieg GK, Ackerson BK, Sharp AL, Skarbinski J, Naik TK, Murali SB. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. 2020;173:773–81.PubMedCrossRef

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, Stachel A. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71:896–7.PubMedCrossRef

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, MacKenna B, Tomlinson L, Douglas IJ, Rentsch CT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L, Goldacre B. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.PubMedPubMedCentralCrossRef

Svensson P, Hofmann R, Häbel H, Jernberg T, Nordberg P. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021;11: e044486.PubMedCrossRef

Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11–30.PubMedCrossRef

Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8:813–22.PubMedPubMedCentralCrossRef

Sokolski M, Trenson S, Sokolska JM, D’Amario D, Meyer P, Poku NK, Biering-Sørensen T, Højbjerg Lassen MC, Skaarup KG, Barge-Caballero E, Pouleur AC, Stolfo D, Sinagra G, Ablasser K, Muster V, Rainer PP, Wallner M, Chiodini A, Heiniger PS, Mikulicic F, Schwaiger J, Winnik S, Cakmak HA, Gaudenzi M, Mapelli M, Mattavelli I, Paul M, Cabac-Pogorevici I, Bouleti C, Lilliu M, Minoia C, Dauw J, Costa J, Celik A, Mewton N, Montenegro CEL, Matsue Y, Loncar G, Marchel M, Bechlioulis A, Michalis L, Dörr M, Prihadi E, Schoenrath F, Messroghli DR, Mullens W, Lund LH, Rosano GMC, Ponikowski P, Ruschitzka F, Flammer AJ. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC Heart Failure. 2021;8:4955–67.PubMedPubMedCentralCrossRef

Myers KD, Wilemon K, McGowan MP, Howard W, Staszak D, Rader DJ. COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD. Am J Prev Cardiol. 2021;7: 100197.PubMedPubMedCentralCrossRef

10.•

O’Hearn M, Liu J, Cudhea F, Micha R, Mozaffarian D. Coronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysis. J Am Heart Assoc. 2021;10:e019259 Findings from this study indicate that major cardiometabolic conditions were key drivers leading to COVID-19 hospitalizations. This highlights the importance of continued public health prevention strategies at such times as the COVID-19 pandemic.PubMedPubMedCentralCrossRef

11.

Flanagan EW, Beyl RA, Fearnbach SN, Altazan AD, Martin CK, Redman LM. The impact of COVID-19 stay-at-home orders on health behaviors in adults. Obesity (Silver Spring, Md). 2021;29:438–45.CrossRef

12.

Barr-Anderson DJ, Hazzard VM, Hahn SL, Folk AL, Wagner BE and Neumark-Sztainer D. Stay-at-home orders during COVID-19: the influence on physical activity and recreational screen time change among diverse emerging adults and future implications for health promotion and the prevention of widening health disparities. Int J Environ Res Public Health. 2021;18.

13.

Rapisarda V, Loreto C, De Angelis L, Simoncelli G, Lombardo C, Resina R, Mucci N, Matarazzo A, Vimercati L, Ledda C. Home working and physical activity during SARS-CoV-2 pandemic: a longitudinal cohort study. Int J Environ Res Public Health 2021;18.

14.

Puccinelli PJ, da Costa TS, Seffrin A, de Lira CAB, Vancini RL, Nikolaidis PT, Knechtle B, Rosemann T, Hill L, Andrade MS. Reduced level of physical activity during COVID-19 pandemic is associated with depression and anxiety levels: an internet-based survey. BMC Public Health. 2021;21:425.PubMedPubMedCentralCrossRef

15.

Strain T, Sharp SJ, Spiers A, Price H, Williams C, Fraser C, Brage S, Wijndaele K, Kelly P. Population level physical activity before and during the first national COVID-19 lockdown: a nationally representative repeat cross-sectional study of 5 years of Active Lives data in England. Lancet Reg Health Eur. 2022;12: 100265.PubMedCrossRef

16.

Dunton GF, Do B, Wang SD. Early effects of the COVID-19 pandemic on physical activity and sedentary behavior in children living in the U.S. BMC Public Health. 2020;20:1351.PubMedCrossRef

17.

Narici M, Vito G, Franchi M, Paoli A, Moro T, Marcolin G, Grassi B, Baldassarre G, Zuccarelli L, Biolo G, di Girolamo FG, Fiotti N, Dela F, Greenhaff P, Maganaris C. Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures. Eur J Sport Sci. 2021;21:614–35.PubMedCrossRef

18.

Sallis R, Young DR, Tartof SY, Sallis JF, Sall J, Li Q, Smith GN, Cohen DA. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients. Br J Sports Med. 2021;55:1099–105.PubMedCrossRef

19.

Zupo R, Castellana F, Sardone R, Sila A, Giagulli VA, Triggiani V, Cincione RI, Giannelli G and De Pergola G. Preliminary trajectories in dietary behaviors during the COVID-19 pandemic: a public health call to action to face obesity. Int J Environ Res Public Health 2020;17.

20.

Bennett G, Young E, Butler I, Coe S. The impact of lockdown during the COVID-19 outbreak on dietary habits in various population groups: a scoping review. Front Nutr. 2021;8: 626432.PubMedPubMedCentralCrossRef

21.

Xu X, Yan AF, Wang Y, Shi Z. Dietary patterns and changes in weight status among Chinese men and women during the COVID-19 pandemic. Front Public Health. 2021;9: 709535.PubMedPubMedCentralCrossRef

22.

Cena H, Fiechtner L, Vincenti A, Magenes VC, De Giuseppe R, Manuelli M, Zuccotti GV and Calcaterra V. COVID-19 pandemic as risk factors for excessive weight gain in pediatrics: the role of changes in nutrition behavior. A narrative review. Nutrients. 2021;13.

23.

Onal HY, Bayram B, Yuksel A. Factors associated with the weight change trend in the first year of the COVID-19 pandemic: the case of Turkey. Nurs Res Pract. 2021;15:S53-s69.

24.

Madalı B, Alkan ŞB, Örs ED, Ayrancı M, Taşkın H, Kara HH. Emotional eating behaviors during the COVID-19 pandemic: a cross-sectional study. Clin Nutr ESPEN. 2021;46:264–70.PubMedPubMedCentralCrossRef

25.

Gwag SH, Oh YR, Ha JW, Kang E, Nam HK, Lee Y, Rhie YJ and Lee KH. Weight changes of children in 1 year during COVID-19 pandemic. J Pediatr Endocrinol Metab: JPEM. 2021.

26.

Endo K, Miki T, Itoh T, Kubo H, Ito R, Ohno K, Hotta H, Kato N, Matsumoto T, Kitamura A, Tamayama M, Wataya T, Yamaya A, Ishikawa R, Ooiwa H. Impact of the COVID-19 pandemic on glycemic control and blood pressure control in patients with diabetes in Japan. Intern Med (Tokyo, Japan). 2022;61:37–48.CrossRef

27.

Biamonte E, Pegoraro F, Carrone F, Facchi I, Favacchio G, Lania AG, Mazziotti G, Mirani M. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 2021;72:604–10.PubMedPubMedCentralCrossRef

28.

Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Prim Care Diabetes. 2021;15:424–7.PubMedPubMedCentralCrossRef

29.

Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, Metoki H, Akai H. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: a hospital-based survey from a country without lockdown. Diabetes Res Clin Pract. 2021;176: 108840.PubMedPubMedCentralCrossRef

30.•

Laffin LJ, Kaufman HW, Chen Z, Niles JK, Arellano AR, Bare LA, Hazen SL. Rise in blood pressure observed among US adults during the COVID-19 pandemic. Circulation. 2022;145:235–7 This study highlights a modest population-level increase in blood pressure during the COVID-19 pandemic. This underscores the continued need for public health interventions during a pandemic to avoid long-term detrimental health effects.PubMedCrossRef

31.

Shah NP, Clare RM, Chiswell K, Navar AM, Shah BR and Peterson ED. Trends of blood pressure control in the U.S. during the COVID-19 pandemic. Am Heart J. 2021.

32.

Dogan-Sander E, Kohls E, Baldofski S, Rummel-Kluge C. More depressive symptoms, alcohol and drug consumption: increase in mental health symptoms among university students after one year of the COVID-19 pandemic. Front Psych. 2021;12: 790974.CrossRef

33.

Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3: e2022942.PubMedPubMedCentralCrossRef

34.

Lee BP, Dodge JL, Leventhal A, Terrault NA. Retail alcohol and tobacco sales during COVID-19. Ann Intern Med. 2021;174:1027–9.PubMedCrossRef

35.

MacKillop J, Cooper A, Costello J. National retail sales of alcohol and cannabis during the COVID-19 pandemic in Canada. JAMA Netw Open. 2021;4: e2133076.PubMedPubMedCentralCrossRef

36.

Bermúdez V, Martínez MS, Chávez-Castillo M, Olivar LC, Morillo J, Mejías JC, Rojas M, Salazar J, Rojas J, Añez R, Cabrera M. Relationship between alcohol consumption and components of the metabolic syndrome in adult population from Maracaibo City Venezuela. Adv Prev Med. 2015;2015: 352547.PubMedPubMedCentralCrossRef

37.

Asare S, Majmundar A, Islami F, Bandi P, Fedewa S, Westmaas LJ and Nargis N. Changes in cigarette sales in the United States during the COVID-19 pandemic. Ann Internal Med. 2021.

38.

The Lancet Respiratory M. Pandemic fans the flames of smoking and health inequity. Lancet Respir Med. 2021;9:435.CrossRef

39.

Cortez C, Mansour O, Qato DM, Stafford RS, Alexander GC. Changes in short-term, long-term, and preventive care delivery in US office-based and telemedicine visits during the COVID-19 pandemic. JAMA Health Forum. 2021;2:e211529–e211529.PubMedCentralCrossRef

40.

Rossano A, Crijns T, Ring D and Reichenberg J. Clinician preferences for current and planned future use of telemedicine. Telemed J E-Health. 2022.

41.

Balut MD, Wyte-Lake T, Steers WN, Chu K, Dobalian A, Ziaeian B, Heyworth L, Der-Martirosian C. Expansion of telemedicine during COVID-19 at a VA specialty clinic. Healthcare (Amsterdam, Netherlands). 2021;10: 100599.

42.

Ismail H, Marshall VD, Patel M, Tariq M and Mohammad RA. The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases. J Am Pharm Assoc. 2021.

43.

Ng BP, Park C, Silverman CL, Eckhoff DO, Guest JC and Díaz DA. Accessibility and utilisation of telehealth services among older adults during COVID-19 pandemic in the United States. Health & social care in the community. 2022.

44.

Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, Adusumalli S. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic: bridging or opening the digital divide? Circulation. 2020;142:510–2.PubMedPubMedCentralCrossRef

45.

Khanna S and Harzand A. Preventive cardiology in the digital and COVID-19 era: a brave new world within the Veterans Health Administration. Healthcare (Basel, Switzerland). 2021;9.

46.

Stewart KA, Blue L, Kranker K, Nelson S, McCall N, Markovich P, Peterson GG. Hospital use for myocardial infarction and stroke among Medicare beneficiaries from March to December 2020. JAMA Cardiol. 2021;6:1340–2.PubMedCrossRef

47.

Kiss P, Carcel C, Hockham C, Peters SAE. The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. 2021;7:18–27.PubMedCrossRef

48.

Evans MC, Steinberg DH, Rhodes JF, Tedford RJ. Ventricular septal defect complicating delayed presentation of acute myocardial infarction during COVID-19 lockdown: a case report. Eur Heart J Case Rep. 2021;5:ytab027.PubMedPubMedCentralCrossRef

49.

Chhetry M, Bhatt R, Tehrani NH, Avgerinos DV, Mack CA, Lang SJ and Dai X. Delayed treatment of acute myocardial infarction with ventricular septal rupture due to patient fear during the COVID-19 pandemic. Texas Heart Inst J. 2021;48.

50.

Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3: e2019686.PubMedPubMedCentralCrossRef

51.

Shah SMA, Mohammad D, Qureshi MFH, Abbas MZ, Aleem S. Prevalence, psychological responses and associated correlates of depression, anxiety and stress in a global population, during the coronavirus disease (COVID-19) pandemic. Community Ment Health J. 2021;57:101–10.PubMedCrossRef

52.

Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, Rasoulpoor S, Khaledi-Paveh B. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health. 2020;16:57.CrossRef

53.

Pearsall R, Shaw RJ, McLean G, Connolly M, Hughes KA, Boyle JG, Park J, Smith DJ, Mackay D. Health screening, cardiometabolic disease and adverse health outcomes in individuals with severe mental illness. BJPsych Open. 2019;5: e97.PubMedPubMedCentralCrossRef

54.

Ringen PA, Faerden A, Antonsen B, Falk RS, Mamen A, Rognli EB, Solberg DK, Andreassen OA, Martinsen EW. Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments. Nord J Psychiatry. 2018;72:296–302.PubMedCrossRef

55.

Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35:1365–72.PubMedCrossRef

56.

Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.PubMedCrossRef

57.

Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976–80.PubMedCrossRef

58.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London, England). 2004;364:937–52.CrossRef

59.

Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105:1049–53.PubMedCrossRef

60.

Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi-amorn C, Sato H, Yusuf S. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet (London, England). 2004;364:953–62.CrossRef

61.

Verdery AM, Smith-Greenaway E, Margolis R, Daw J. Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States. Proc Natl Acad Sci USA. 2020;117:17695–701.PubMedPubMedCentralCrossRef

62.

Ott CH. The impact of complicated grief on mental and physical health at various points in the bereavement process. Death Stud. 2003;27:249–72.PubMedCrossRef

63.

Ellis J, Dowrick C, Lloyd-Williams M. The long-term impact of early parental death: lessons from a narrative study. J R Soc Med. 2013;106:57–67.PubMedPubMedCentralCrossRef

64.

Woodbury PFaSA. "Update: how many Americans have lost jobs with employer health coverage during the pandemic?" To the Point (blog), Commonwealth Fund, Jan 11, 2021.

65.

Niles MT, Bertmann F, Belarmino EH, Wentworth T, Biehl E and Neff R. The early food insecurity impacts of COVID-19. Nutrients. 2020;12.

66.

McKnight-Eily LR, Okoro CA, Strine TW, Verlenden J, Hollis ND, Njai R, Mitchell EW, Board A, Puddy R, Thomas C. Racial and ethnic disparities in the prevalence of stress and worry, mental health conditions, and increased substance use among adults during the COVID-19 pandemic - United States, April and May 2020. MMWR Morb Mortal Wkly Rep. 2021;70:162–6.PubMedPubMedCentralCrossRef

67.

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–646.PubMedPubMedCentral

68.

O’Donoghue G, Blake C, Cunningham C, Lennon O, Perrotta C. What exercise prescription is optimal to improve body composition and cardiorespiratory fitness in adults living with obesity? A network meta-analysis. Obes Rev. 2021;22: e13137.PubMedCrossRef

69.

Hooker S, Punjabi A, Justesen K, Boyle L, Sherman MD. Encouraging health behavior change: eight evidence-based strategies. Fam Pract Manag. 2018;25:31–6.PubMed

70.

Phillips EM, Kennedy MA. The exercise prescription: a tool to improve physical activity. PM R. 2012;4:818–25.PubMedCrossRef

71.

Faulkner J, O’Brien WJ, McGrane B, Wadsworth D, Batten J, Askew CD, Badenhorst C, Byrd E, Coulter M, Draper N, Elliot C, Fryer S, Hamlin MJ, Jakeman J, Mackintosh KA, McNarry MA, Mitchelmore A, Murphy J, Ryan-Stewart H, Saynor Z, Schaumberg M, Stone K, Stoner L, Stuart B, Lambrick D. Physical activity, mental health and well-being of adults during initial COVID-19 containment strategies: a multi-country cross-sectional analysis. J Sci Med Sport. 2021;24:320–6.PubMedCrossRef

72.

King HA, Gierisch JM, Williams JW Jr, Maciejewski ML. VA evidence-based synthesis program reports. Effects of health plan-sponsored fitness center benefits on physical activity, health outcomes, and health care costs and utilization: a systematic review. Washington (DC): Department of Veterans Affairs (US); 2012.

73.

Ramage S, Farmer A, Eccles KA, McCargar L. Healthy strategies for successful weight loss and weight maintenance: a systematic review. Appl Physiol Nutr Metab. 2014;39:1–20.PubMedCrossRef

74.

Bray GA, Ryan DH. Evidence-based weight loss interventions: individualized treatment options to maximize patient outcomes. Diabetes Obes Metab. 2021;23(Suppl 1):50–62.PubMedCrossRef

75.

Brunton C, Arensberg MB, Drawert S, Badaracco C, Everett W and McCauley SM. Perspectives of registered dietitian nutritionists on adoption of telehealth for nutrition care during the COVID-19 pandemic. Healthcare (Basel, Switzerland). 2021;9.

76.

Cohen JB, Gadde KM. Weight loss medications in the treatment of obesity and hypertension. Curr Hypertens Rep. 2019;21:16.PubMedPubMedCentralCrossRef

77.

Gadde KM, Atkins KD. The limits and challenges of antiobesity pharmacotherapy. Expert Opin Pharmacother. 2020;21:1319–28.PubMedPubMedCentralCrossRef

78.

Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989.PubMedCrossRef

79.

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022:Cir0000000000001052.

80.

Ho PM, Rumsfeld JS. Beyond inpatient and outpatient care: alternative model for hypertension management. BMC Public Health. 2006;6:257.PubMedPubMedCentralCrossRef

81.

Treskes RW, van Winden LAM, van Keulen N, van der Velde ET, Beeres S, Atsma DE, Schalij MJ. Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial. JAMA Netw Open. 2020;3: e202165.PubMedPubMedCentralCrossRef

82.

Juraschek SP, Miller ER 3rd, Weaver CM, Appel LJ. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. J Am Coll Cardiol. 2017;70:2841–8.PubMedPubMedCentralCrossRef

83.

Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri M-A, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS. 2018 ACC expert consensus decision pathway on tobacco cessation treatment. J Am Coll Cardiol. 2018;72:3332–65.PubMedCrossRef

84.

Patel P, Dhindsa D, Eapen DJ, Khera A, Gulati M, Stone NJ, Yancy CW, Rumsfeld JS, Sperling LS. Optimizing the potential for telehealth in cardiovascular care (in the era of COVID-19): time will tell. Am J Med. 2021;134:945–51.PubMedPubMedCentralCrossRef

85.

Al Rifai M, Shapiro MD, Sayani S, Gulati M, Levine G, Rodriguez F, Mahtta D, Khera A, Petersen LA, Virani SS. Racial and geographic disparities in internet use in the United States among patients with atherosclerotic cardiovascular disease. Am J Cardiol. 2020;134:146–7.PubMedPubMedCentralCrossRef

86.

Kelly SA, Schesing KB, Thibodeau JT, Ayers CR, Drazner MH. Feasibility of remote video assessment of jugular venous pressure and implications for telehealth. JAMA Cardiol. 2020;5:1194–5.PubMedPubMedCentralCrossRef

87.

Harrington RA, Califf RM, Balamurugan A, Brown N, Benjamin RM, Braund WE, Hipp J, Konig M, Sanchez E, Joynt Maddox KE. Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association. Circulation. 2020;141:e615–44.PubMedCrossRef

88.

Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE, Franklin BA, Keteyian SJ, Kitzman DW, Regensteiner JG, Sanderson BK, Whooley MA. Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. Circulation. 2019;140:e69–89.PubMedCrossRef

89.

Anderson L, Sharp GA, Norton RJ, Dalal H, Dean SG, Jolly K, Cowie A, Zawada A, Taylor RS. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2017;6:Cd007130.PubMed

90.

Brooks EL, Preis SR, Hwang SJ, Murabito JM, Benjamin EJ, Kelly-Hayes M, Sorlie P, Levy D. Health insurance and cardiovascular disease risk factors. Am J Med. 2010;123:741–7.PubMedPubMedCentralCrossRef

91.

Li S, Bruen BK, Lantz PM, Mendez D. Impact of health insurance expansions on nonelderly adults with hypertension. Prev Chronic Dis. 2015;12:E105.PubMedPubMedCentralCrossRef

92.

De Simone V, Guarise P, Guardalben S, Padovani N, Tondelli S, Sandrini D, Visentin E, Zanotto G. Telecardiology during the COVID-19 pandemic: past mistakes and future hopes. Am J Cardiovasc Dis. 2020;10:34–47.PubMedPubMedCentral

93.

Hincapié MA, Gallego JC, Gempeler A, Piñeros JA, Nasner D, Escobar MF. Implementation and usefulness of telemedicine during the COVID-19 pandemic: a scoping review. J Prim Care Commun Health. 2020;11:2150132720980612.CrossRef

94.

Zachrison KS, Boggs KM, Hayden EM, Espinola JA, Camargo CA Jr. Understanding barriers to telemedicine implementation in rural emergency departments. Ann Emerg Med. 2020;75:392–9.PubMedCrossRef

95.

Arora S, Hendrickson MJ, Mazzella AJ, Vaduganathan M, Chang PP, Rossi JS, Qamar A, Pandey A, Vavalle JP, Weickert TT, Strassle PD, Yeung M, Stouffer GA. Effect of government-issued state of emergency and reopening orders on cardiovascular hospitalizations during the COVID-19 pandemic. Am J Prevent Cardiol 2021;6

96.

Wong LE HJ, Langness S, Murrell KL, Iris P, Sammann A. Where are all the patients? Addressing COVID-19 fear to encourage sick patients to seek emergency care. NEJM catalyst - Innovations in Care Delivery May 2020

97.••

Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, Navar AM, Taub PR, Toth PP, Virani SS, Wong ND, Shapiro MD. Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: a scientific statement from the American Society for Preventive Cardiology. Am J Prevent Cardiol. 2020;1:100009 This scientific statement from the American Society of Preventive Cardiology proposes several important strategies to ensure continuity of care during the COVID-19 pandemic, particularly for patients with or at high risk for cardiovascular disease.CrossRef

Titel: COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave
verfasst von: Ahmed A. Kolkailah
Kayla Riggs
Ann Marie Navar
Amit Khera
Publikationsdatum: 01.07.2022
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current Atherosclerosis Reports / Ausgabe 8/2022
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-022-01033-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?

Statins in Pregnancy: Can We Justify Early Treatment of Reproductive Aged Women?

Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?

Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions